
Fadi Haddad, MD, discusses how to approach proper TKI adherence and selection in clinical practice for CML.

Fadi Haddad, MD, is an assistant professor and co-leader of the Section of Chronic Myeloid Leukemia in the Department of Leukemia in the Division of Cancer Medicine at The University of Texas MD Anderson Cancer Center.

Fadi Haddad, MD, discusses how to approach proper TKI adherence and selection in clinical practice for CML.

Fadi Haddad, MD, discusses the efficacy of asciminib in patients with newly diagnosed chronic myeloid leukemia as seen in a phase 2 trial.

Fadi Haddad, MD, discusses updates on the treatment of chronic myeloid leukemia failing frontline therapy.